Found vs MyStart Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent researchHow we rank →

MyStart Health beats Found overall, scoring 7.7/10 vs 7.3/10. Found is more affordable at $264/mo vs $299/mo. Choose Found for users who want a science-backed weight loss program with beh. Choose MyStart Health for users who value a money-back weight-loss guarantee and price.

A side-by-side comparison of Found and MyStart Health covering pricing, scores, medication types, insurance, and more to help you decide.

Found

#37 of 48
7.3/10

Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.

Visit Found
Higher Rated

MyStart Health

#23 of 48
7.7/10

GLP-1 provider offering a unique money-back guarantee and price-lock protection for long-term cost certainty.

Visit MyStart Health
FeatureFoundMyStart Health
Our Score7.3/107.7/10
Starting Price$264/mo$299/mo
Medication TypeBothCompounded
Insurance AcceptedYesNo
Best ForUsers who want a science-backed weight loss program with behavior change supportUsers who value a money-back weight-loss guarantee and price-lock protection
Ranking#37#23

Pros & Cons Compared

Found

Pros

  • +Active insurance coordination — Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
  • +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill) — the widest formulary of any platform
  • +Typical insured copay of ~$30/mo for most members — dramatically lower than cash-pay alternatives
  • +Most members start treatment within one week of completing the health questionnaire

Cons

  • Pricing is less transparent than flat-rate competitors — costs vary by insurance status and medication choice
  • The insurance navigation process adds steps and complexity compared to simple cash-pay platforms
  • Compounded medication availability may shift with FDA enforcement changes

MyStart Health

Pros

  • +Price Lock Guarantee ensures your monthly rate never increases even as your GLP-1 dose escalates — a genuine differentiator
  • +Access to 600+ board-certified doctors with unlimited clinician messaging at no additional cost
  • +Competitive pricing at $149-$179/mo for compounded semaglutide with free shipping included
  • +HSA/FSA eligible — can use pre-tax health savings to pay for treatment

Cons

  • Cash-pay only — no insurance accepted, which limits options for patients with GLP-1 coverage
  • Only available in select states — not all 50, and the exact state list isn't published
  • Compounded medications only — no brand-name GLP-1 options available

Our Verdict

MyStart Health edges out Found with a score of 7.7/10 vs 7.3/10. If budget is your priority, Found starts at $264/mo compared to MyStart Health's $299/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Found offers both brand-name and compounded medications, giving you more flexibility. Choose Found if you want: users who want a science-backed weight loss program with behavior change support. Choose MyStart Health if you want: users who value a money-back weight-loss guarantee and price-lock protection.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Found nor MyStart Health feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try Found

Starting at $264/mo

Visit Found

Try MyStart Health

Starting at $299/mo

Visit MyStart Health

Related comparisons

Other matchups readers comparing Found or MyStart Health tend to look at next.

Top Picks

Four programs our readers click through most.

Eden Health GLP-1

8.9/10
$249/mo·Brand & Compounded

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.